220 related articles for article (PubMed ID: 31928731)
1. Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils.
Siddiqi MK; Malik S; Majid N; Alam P; Khan RH
Adv Protein Chem Struct Biol; 2019; 118():333-369. PubMed ID: 31928731
[TBL] [Abstract][Full Text] [Related]
2. Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors.
Lee SJ; Nam E; Lee HJ; Savelieff MG; Lim MH
Chem Soc Rev; 2017 Jan; 46(2):310-323. PubMed ID: 27878186
[TBL] [Abstract][Full Text] [Related]
3. Amyloid Oligomers, Protofibrils and Fibrils.
Siddiqi MK; Majid N; Malik S; Alam P; Khan RH
Subcell Biochem; 2019; 93():471-503. PubMed ID: 31939162
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
5. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
[TBL] [Abstract][Full Text] [Related]
6. Why are Functional Amyloids Non-Toxic in Humans?
Jackson MP; Hewitt EW
Biomolecules; 2017 Sep; 7(4):. PubMed ID: 28937655
[TBL] [Abstract][Full Text] [Related]
7. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.
Stefani M
Prog Neurobiol; 2012 Dec; 99(3):226-45. PubMed ID: 22450705
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization and biological properties of the amyloidogenic elastin-like peptide (VGGVG)3.
Moscarelli P; Boraldi F; Bochicchio B; Pepe A; Salvi AM; Quaglino D
Matrix Biol; 2014 Jun; 36():15-27. PubMed ID: 24686253
[TBL] [Abstract][Full Text] [Related]
9. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
10. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the Role of Lipids in the Aggregation of Amyloidogenic Proteins.
Kurouski D
Acc Chem Res; 2023 Nov; 56(21):2898-2906. PubMed ID: 37824095
[TBL] [Abstract][Full Text] [Related]
12. Amyloid Oligomers and Mature Fibrils Prepared from an Innocuous Protein Cause Diverging Cellular Death Mechanisms.
Harte NP; Klyubin I; McCarthy EK; Min S; Garrahy SA; Xie Y; Davey GP; Boland JJ; Rowan MJ; Mok KH
J Biol Chem; 2015 Nov; 290(47):28343-28352. PubMed ID: 26221033
[TBL] [Abstract][Full Text] [Related]
13. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
14. Insulin and Lispro Insulin: What is Common and Different in their Behavior?
Selivanova OM; Suvorina MY; Surin AK; Dovidchenko NV; Galzitskaya OV
Curr Protein Pept Sci; 2017; 18(1):57-64. PubMed ID: 27226198
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights into the role of amyloid-β in innate immunity.
Prosswimmer T; Heng A; Daggett V
Sci Rep; 2024 Mar; 14(1):5376. PubMed ID: 38438446
[TBL] [Abstract][Full Text] [Related]
16. Toxic species in amyloid disorders: Oligomers or mature fibrils.
Verma M; Vats A; Taneja V
Ann Indian Acad Neurol; 2015; 18(2):138-45. PubMed ID: 26019408
[TBL] [Abstract][Full Text] [Related]
17. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
Klein WL
J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
[TBL] [Abstract][Full Text] [Related]
18. Misfolding of amyloidogenic proteins and their interactions with membranes.
Relini A; Marano N; Gliozzi A
Biomolecules; 2013 Dec; 4(1):20-55. PubMed ID: 24970204
[TBL] [Abstract][Full Text] [Related]
19. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
